The main objective of this meeting is to provide open sessions to EuroQol members, that relate to the theme of this year’s meeting, which is: ‘EuroQol instruments in today’s world: exploring new frontiers’ Global interest in EQ-5D vastly exceeds what… Read More »8th EuroQol Academy Meeting
Poster presentations Guided poster sessions are scheduled for Wednesday 6th March. A moderator will lead viewers through each poster in turn, and the poster authors will be available for questions and clarifications. Each poster will be discussed for approximately 5-7… Read More »Deadline: 8th EuroQol Academy Meeting abstracts
With a programme of research challenging current approaches to health state measurement and valuation, and all things EQ-5D, Chris provides his take on the latest EuroQol meeting.
We kindly remind you that the Call for Abstracts for the 40th EuroQol Plenary 2023 on Wednesday 20 and Thursday 21 September is still OPEN! We invite you to submit an abstract through the EuroQol Abstract Collection Portal below at… Read More »Abstract deadline: 40th EuroQol Plenary
The EuroQol Group Association has been holding annual Plenary Meetings since its inception in 1987. During the scientific sessions, members and co-workers of the EuroQol Group present papers on topics that include methodological/valuation aspects of EQ-5D; development of EQ-5D versions… Read More »40th EuroQol Plenary
Chris provides a report on the recent EuroQol Academy meeting, with the theme ‘From cradle to grave: can we measure and value HRQoL consistently over the lifespan?’
David Mott reviews this supplement dedicated to the youth version of the EQ-5D. The research tackles many methodological and theoretical challenges for the the valuation of the EQ-5D-Y-3L instrument.
The EQ Valuation Technology (EQ-VT) protocol has been widely used in the valuation of EuroQol instruments, including in over 25 national EQ-5D-5L value sets and, in an adapted form, the valuation of EQ-5D-Y-3L. Adapted versions of it are also currently… Read More »The ‘wheelchair example’ – why it should be dropped from EQ-5D valuation tasks
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Chris Sampson’s journal round-up for 2nd April 2018
We’ve seen a few editorials and commentaries popping up about the EQ-5D-5L recently, in Health Economics, PharmacoEconomics, and PharmacoEconomics again. All of these articles have – to varying extents – acknowledged the need for NICE to exercise caution in the… Read More »Bad reasons not to use the EQ-5D-5L